Today could be a defining moment in your life
Dear subscriber,
Two weeks ago, after a long hiatus, I sent you a stock tip which I believed would produce huge gains.
I was wrong. It was one of those rare ones that represent 1-2% of all my picks which severely underperforms.
The good news is that this has NEVER happened twice in a row. I am 1000% confident in the stock I have to tell you about today.
I made extremely sure of that because I want to redeem myself. I want to make you a fortune. I want you to be happy and thank me later.
I want to talk to you about a stunning breakthrough in artificial intelligence that is set to disrupt the entire world.
A.I. has the power to precisely predict whether a person’s future holds the potential to develop deadly diseases and sickness – threatening maladies such as diabetes, or cancers of the prostate, breast, lung, ovaries, and colon.
But, only one young Utah-based company has this early-warning, disease-predicting A.I.
That market could be vast because the A.I. is aimed squarely at consumers. Because of that, shares in the Utah-based company behind the A.I. could soar.
A.I. won’t let people cheat death – but this advanced technology delivers a first alert that can help people take steps to stave off diseases.
That’s because the advanced A.I. technology uses a small sample that contains DNA, then the A.I. delves deep into genetic makeup to precisely predict a person’s future risk of developing serious diseases or health complications.
The A.I.’s clear implication for dramatically bettering human lives is why investors need to move now on a still-under-the-radar opportunity with Frélii, Inc. It trades under the symbol FRLI
There’s nothing like it on the market now.
Moreover, while there is a lively direct-to-consumer DNA testing market, Frélii's sophisticated A.I. is a radical advance compared to commonplace DNA tests.
The difference is, other companies test DNA to help people discover their ancestral roots. But, Frélii's A.I. is on the vanguard of a new field called precision genomics.
FRLI is spearheading the precision genomics direct-to-consumer market because its A.I. analyzes 60 million genomic data points. That’s a whopping 10 times greater than other DTC DNA testing companies, which only analyze about 6 million data points.
Because of the massive amount of genomic data that the A.I. generates, Frélii's clients can now create new types of personalized lifestyle and healthcare strategies.
These personalized action plans can range from disease prevention, to improved nutrition, to determining the most effective drugs to treat medical problems, to advice on the most effective diets and exercise. The A.I. will even make personal grocery shopping lists.
There’s huge profit potential in unlocking secrets hidden deep in DNA.
In short, Frélii's precision genomics unlocks the door to a radical new form of healthcare – personalized healthcare based on specific individual genomic data.
It means a woman with the BRAC/1 gene variant that could cause deadly ovarian cancer has advanced warning of a cancer that is hard to detect unless doctors know what they are looking for.
It’s why ovarian cancer is deadly. Women may have no symptoms or just mild symptoms until the disease is in an advanced stage.
Using Frélii's A.I., women can make a plan with their doctors that includes early detection of precancerous tissue before it turns into a cancer that spreads through the body. The sooner ovarian cancer is found and treated, the better the chances are for recovery.
The same could hold true for prostate cancer, which is often caused by a BRAC/1 or BRAC/2 gene mutation.
Prostate cancer is the second leading cause of cancer death in men in the United States. The average age of detection is 66 years old.
So, advanced knowledge could encourage earlier testing in men who have the gene mutation.
The A.I megatrend is disrupting the health supplement market.
Frélii's A.I. has also taken another huge step forward in personalized individual health strategies.
That’s because poor nutrition plays an outsized role in causing disease, and its root cause could be hidden deep in DNA. The search for genetic nutrition problems even has a name – nutrigenomics.
After deep-diving into DNA, Frélii's A.I. uses nutrigenomic data to develop individual diet and nutrition plans that optimize health.
Frélii goes as far as stocking a huge number of nutritional supplements it can sell to its clients to optimize their nutrient balance.
So, if you are deficient in Vitamin D, it can tell.
In fact, it can tell by how much, just from your individual DNA.
If you have too much Vitamin C, it can tell.
And, it can provide you with the right amount, for your individual needs.
This will be the supplement megatrend that changes the way the world takes supplements.
A Potential Windfall for Shareholders
After running the numbers – and examining the company closely – I feel that FRLI is a one-of-a-kind company with a competitive advantage.
With that said, as I did with my readers, I am recommending Frélii, Inc. (FRLI) to you because it’s the rare young company that could actually disrupt a mature marketplace.
The company is actively working on spreading its technologies and just a few weeks ago FRLI’s CEO had a face-to-face meeting with Canada’s prime minister Justin Trudeau.
FRLI could enter the Cannabis business as a top player by analyzing consumers’ DNA and suggesting for them the perfect dosage and strain of plant that they need to use for the desired result.
This $1.60 stock could be trading as high as $20 by the end of the summer.
I have never seen a company with as much potential as FRLI.
I highly recommend you buy shares as soon as possible before this sleeping giant’s stock price rises thousands of percent.
This is one of the best BUY AND HOLD stocks I have seen in my entire life as an analyst.
In my opinion, it is the Uber of the medical industry. A small company, rising out of no-where in Utah and that could change how the average human interacts with his/her personal DNA forever.
A $5,000 investment into FRLI could make you a millionaire in a couple of years and could easily allow you to quadruple in the next 4-6 weeks.
ACT NOW AND BUY SHARES OF THIS HIDDEN GEM BEFORE THE MASSES GET AHOLD OF IT
Sincerely,
Kelvin Powell
Editor / PennyStockProPicks.com
© 2019 | PennyStockProPicks.com | All Rights Reserved.
If you would like to unsubscribe, please click on this link
Unsubscribe
This message was sent to santoalbanese@gmail.com from info@PennyStockProPicks.com
PennyStockProPicks.com
60 Kings Lane
Fayetteville, NC 28307
